These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30919524)
1. Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy. Wang NC; Mezu-Chukwu U; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12641. PubMed ID: 30919524 [TBL] [Abstract][Full Text] [Related]
2. Myocardial recovery after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy. Wang NC; Hussain A; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12603. PubMed ID: 30267454 [TBL] [Abstract][Full Text] [Related]
3. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study. Wang NC; Li JZ; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S Pacing Clin Electrophysiol; 2018 Feb; 41(2):143-154. PubMed ID: 29314085 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy. Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539 [TBL] [Abstract][Full Text] [Related]
5. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study. Wang NC; Singh M; Adelstein EC; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S Heart Rhythm; 2016 Apr; 13(4):933-42. PubMed ID: 26688064 [TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821 [TBL] [Abstract][Full Text] [Related]
9. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490 [TBL] [Abstract][Full Text] [Related]
10. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT. Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ; Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234 [TBL] [Abstract][Full Text] [Related]
11. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570 [TBL] [Abstract][Full Text] [Related]
12. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
13. Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome. Zweerink A; Friedman DJ; Klem I; van de Ven PM; Vink C; Biesbroek PS; Hansen SM; Emerek K; Kim RJ; van Rossum AC; Atwater BD; Nijveldt R; Allaart CP Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006767. PubMed ID: 30541355 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block. Kawata H; Bao H; Curtis JP; Minges KE; Mitiku T; Birgersdotter-Green U; Feld GK; Hsu JC J Am Coll Cardiol; 2019 Jun; 73(24):3082-3099. PubMed ID: 31221257 [TBL] [Abstract][Full Text] [Related]
15. Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials. Friedman DJ; Al-Khatib SM; Dalgaard F; Fudim M; Abraham WT; Cleland JGF; Curtis AB; Gold MR; Kutyifa V; Linde C; Tang AS; Ali-Ahmed F; Olivas-Martinez A; Inoue LYT; Sanders GD Circulation; 2023 Mar; 147(10):812-823. PubMed ID: 36700426 [TBL] [Abstract][Full Text] [Related]
16. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR. Zusterzeel R; Curtis JP; Caños DA; Sanders WE; Selzman KA; Piña IL; Spatz ES; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Strauss DG J Am Coll Cardiol; 2014 Sep; 64(9):887-94. PubMed ID: 25169173 [TBL] [Abstract][Full Text] [Related]
17. Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of ∼ 145,000 patients. Loring Z; Caños DA; Selzman K; Herz ND; Silverman H; MaCurdy TE; Worrall CM; Kelman J; Ritchey ME; Piña IL; Strauss DG JACC Heart Fail; 2013 Jun; 1(3):237-44. PubMed ID: 24621876 [TBL] [Abstract][Full Text] [Related]
18. Cardiac Resynchronization Therapy and Risk of Recurrent Hospitalizations in Patients Without Left Bundle Branch Block: The Long-Term Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy. Vidula H; Lee E; McNitt S; Polonsky B; Aktas M; Rosero S; Younis A; Solomon SD; Zareba W; Kutyifa V; Goldenberg I Circ Heart Fail; 2020 Jul; 13(7):e006925. PubMed ID: 32605387 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ; Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819 [TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]